Midline Assembloids for Human Neurodevelopment Modeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack the capability to generate functional human three-dimensional neural organizers that can model human neurodevelopment and study neuropsychiatric disorders in vitro.

Innovation Solution

The development of compositions and methods for generating functional human three-dimensional neural organizers from human induced pluripotent stem cells (hiPSC), specifically floor plate and roof plate organoids, which can be fused to form midline assembloids, capable of inducing specific cell fate and cell-cell interactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional in vitro methods are used for studying neural development, then accessibility to human neural tissues is limited, but the ability to model human neurodevelopment and study genetic disorders is insufficient

Engineering Contradiction:
Improvemodeling capabilityVSAvoidaccessibility
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent creates in vitro copies of human neural tissues (floor plate organoids, roof plate organoids, and midline assembloids) that replicate the structure and function of actual human neural organizer tissues. These organoid models serve as accessible substitutes for studying human neurodevelopment and genetic disorders without requiring access to actual human fetal tissues.

Inventive Principle:
Principle #26Copying

2Reliability

If functional human three-dimensional neural organizers are generated from hiPSC, then the ability to model human neurodevelopment is improved, but the complexity of the generation process increases

Engineering Contradiction:
Improvefunctional modeling capabilityVSAvoidgeneration process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent divides the complex task of creating functional neural organizers into separate, manageable components: floor plate organoids, roof plate organoids, and neural tube organoids. Each component is generated through standardized protocols and then assembled into midline assembloids, making the overall process more controllable and reproducible.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent performs preliminary differentiation of hiPSCs into specific neural progenitor populations (floor plate, roof plate, and neural tube progenitors) before assembly. This preliminary action ensures that each organoid component is pre-configured with the appropriate cell types and signaling capabilities needed for functional integration in the final assembloid.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If midline assembloids are assembled from component organoids, then the ability to study cell fate and cell-cell interactions is improved, but the time and resources required for assembly increase

Engineering Contradiction:
Improvecell interaction study capabilityVSAvoidassembly time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent separates the generation of different organoid components (floor plate, roof plate, neural tube) into independent parallel processes. This segmentation allows each component to be optimized and prepared simultaneously, reducing the overall assembly time when combining them into midline assembloids.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20250076286A1Generation of neural organizer organoids and midline assembloids from human pluripotent stem cells
Publication Date: 2025.03.06 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
  • US20250076286A1 patent drawing
  • US20250076286A1 patent drawing
  • US20250076286A1 patent drawing

AI summary

Compositions and methods are provided for the in vitro generation of functional human three-dimensional neural organizers that are functionally active and capable of choreographing in vitro midline brain development from human induced pluripotent stem cells (hiPSC). Demonstrated is a model of floor plate organizer ventral midline neurodevelopment, via the expression of a full compendium of axon guidance, morphogen, and cell signaling molecules. Floor plate organoids can be fused with spinal cord organoids into midline assembloids to induce specific cell fate and cell-cell interactions at the interface. This powerful platform can be used to model human neurodevelopment, study human genetic disorders that result from neural development, identify toxic molecules or drugs that disrupt midline brain development, and screen for therapeutics that could repair or rescue these defects.